Literature DB >> 3455782

Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells.

V P Terranova, E S Hujanen, D M Loeb, G R Martin, L Thornburg, V Glushko.   

Abstract

Malignant cells must traverse basement membranes during their migration to sites distant from the primary tumor. Since basement membranes are thought to be a critical barrier to the passage of tumor cells, we have constructed a model basement membrane-stromal matrix consisting of laminin and type IV collagen reconstituted onto a disk of type I collagen for use in an in vitro assay of invasiveness. Metastatic tumor cells and leukocytes are able to cross this barrier, whereas nonmetastatic tumor cells, fibroblasts, and epidermal cells cannot penetrate it. Those tumor cells that penetrate the barriers were found, when isolated and subcultured, to be more invasive and to produce more metastases than the parental population. This assay system should be useful for studying the invasiveness of tumor cells and for isolating highly invasive variants.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3455782      PMCID: PMC322880          DOI: 10.1073/pnas.83.2.465

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Role of laminin in the attachment of PAM 212 (epithelial) cells to basement membrane collagen.

Authors:  V P Terranova; D H Rohrbach; G R Martin
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

2.  Loss of basement membrane components by invasive tumors but not by their benign counterparts.

Authors:  S H Barsky; G P Siegal; F Jannotta; L A Liotta
Journal:  Lab Invest       Date:  1983-08       Impact factor: 5.662

Review 3.  Tumor cell diversity and host responses in cancer metastasis--part I--properties of metastatic cells.

Authors:  G L Nicolson; G Poste
Journal:  Curr Probl Cancer       Date:  1982-12       Impact factor: 3.187

Review 4.  The implications of tumor heterogeneity for studies on the biology of cancer metastasis.

Authors:  I R Hart; I J Fidler
Journal:  Biochim Biophys Acta       Date:  1981-08-31

5.  In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties.

Authors:  G Poste; J Doll; I R Hart; I J Fidler
Journal:  Cancer Res       Date:  1980-05       Impact factor: 12.701

6.  Role of laminin in the attachment and metastasis of murine tumor cells.

Authors:  V P Terranova; L A Liotta; R G Russo; G R Martin
Journal:  Cancer Res       Date:  1982-06       Impact factor: 12.701

7.  Laminin receptor on human breast carcinoma cells.

Authors:  V P Terranova; C N Rao; T Kalebic; I M Margulies; L A Liotta
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

8.  Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma.

Authors:  H K Kleinman; M L McGarvey; L A Liotta; P G Robey; K Tryggvason; G R Martin
Journal:  Biochemistry       Date:  1982-11-23       Impact factor: 3.162

9.  Isolation of a cell surface receptor protein for laminin from murine fibrosarcoma cells.

Authors:  H L Malinoff; M S Wicha
Journal:  J Cell Biol       Date:  1983-05       Impact factor: 10.539

10.  Metastasizing capacity of tumour cells from spontaneous metastases of transplanted murine tumours.

Authors:  R Giavazzi; G Alessandri; F Spreafico; S Garattini; A Mantovani
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640

View more
  39 in total

1.  Quantitative evaluation of the growth of established cell lines on the surface of collagen, collagen composite and reconstituted basement membrane.

Authors:  M D Smith; M G Shearer; S Srivastava; R Scott; J M Courtney
Journal:  Urol Res       Date:  1992

2.  Effects of extracellular matrix analogues on primary human fibroblast behavior.

Authors:  Monica A Serban; Yanchun Liu; Glenn D Prestwich
Journal:  Acta Biomater       Date:  2007-09-29       Impact factor: 8.947

3.  Quantitative characterization of binding of small molecules to extracellular matrix.

Authors:  Yufen Zhang; Viera Lukacova; Katie Reindl; Stefan Balaz
Journal:  J Biochem Biophys Methods       Date:  2006-02-17

4.  Effects of extracellular matrix and neighboring cells on induction of human embryonic stem cells into retinal or retinal pigment epithelial progenitors.

Authors:  Jie Gong; Ofer Sagiv; Hui Cai; Stephen H Tsang; Lucian V Del Priore
Journal:  Exp Eye Res       Date:  2008-03-28       Impact factor: 3.467

5.  A novel in vitro assay system for transendothelial tumor cell invasion: significance of E-selectin and alpha 3 integrin in the transendothelial invasion by HT1080 fibrosarcoma cells.

Authors:  T Okada; H Okuno; Y Mitsui
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

6.  Venous invasion as a prognostic factor in colorectal cancer.

Authors:  A Tsuchiya; Y Ando; Y Kikuchi; M Kanazawa; H Sato; R Abe
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

7.  Quantitative method for in vitro matrigel invasiveness measurement through image analysis software.

Authors:  Gabriel Gallo-Oller; Juan A Rey; Javier Dotor; Javier S Castresana
Journal:  Mol Biol Rep       Date:  2014-07-03       Impact factor: 2.316

8.  Development of an in vitro extracellular matrix assay for studies of brain tumor cell invasion.

Authors:  A P Amar; S J DeArmond; D R Spencer; P F Coopersmith; D M Ramos; M L Rosenblum
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype.

Authors:  C Collesi; M M Santoro; G Gaudino; P M Comoglio
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells.

Authors:  Chao-Jie Wang; Johannes Stratmann; Zong-Guang Zhou; Xiao-Feng Sun
Journal:  BMC Cancer       Date:  2010-11-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.